Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENDOXAN for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where ENDOXAN was used for Bone marrow conditioning regimen.

Most Reported Side Effects for ENDOXAN

Side Effect Reports % Deaths Hosp.
Death 56 13.4% 56 0
No adverse event 37 8.9% 0 0
Maternal exposure before pregnancy 26 6.2% 0 0
Musculoskeletal disorder 25 6.0% 0 0
Toxicity to various agents 24 5.7% 8 0
Disease progression 21 5.0% 6 1
Febrile neutropenia 20 4.8% 0 3
Disease recurrence 19 4.6% 3 0
Pneumonia 15 3.6% 3 1
Acute graft versus host disease 14 3.4% 1 0
Bone marrow failure 11 2.6% 3 3
Drug ineffective 11 2.6% 6 1
Exposure via father 11 2.6% 0 0
Pyrexia 11 2.6% 2 9
Breast cancer recurrent 10 2.4% 0 0

Other Indications for ENDOXAN

Breast cancer stage i (58) Stem cell transplant (49) Neoplasm malignant (37) Lupus nephritis (24) Chronic lymphocytic leukaemia (23) Breast cancer (21) Plasma cell myeloma (21) B-cell lymphoma (14) Diffuse large b-cell lymphoma (14) Temporal arteritis (12)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

ENDOXAN Full Profile All Bone marrow conditioning regimen Drugs ENDOXAN Demographics ENDOXAN Timeline